Diabetologie und Stoffwechsel 2025; 20(S 01): S96-S97
DOI: 10.1055/s-0045-1807550
DOI: 10.1055/s-0045-1807550
Abstracts | DDG 2025
Poster
Posterwalk 15: Sonstige Themen
Analyse nicht-invasiver Leberbiomarker in einer Phase-II-Studie des dualen Glucagon- und GLP-1-Rezeptoragonisten Survodutid bei Menschen mit metabolischer Dysfunktion-assoziierter Steatohepatitis (MASH) und Fibrose
Authors
-
J M Schattenberg
1 Universität des Saarlandes, Klinik für Innere Medizin II, Homburg, Germany -
M Noureddin
2 Houston Methodist Hospital and Houston Research Institute, Hepatology, Houston, United States -
C Schoelch
3 Boehringer Ingelheim Pharma GmbH & Co. KG, TMCP Therapeutic Areas, Biberach, Germany -
E Bugianesi
4 University of Turin, Department of Medical Sciences, Division of Gastroenterology, Turin, Italy -
N Alkhouri Alkhouri
5 University of Texas Health San Antonio, The Texas Liver Institute, San Antonio, United States -
M Fraessdorf
6 Boehringer Ingelheim International GmbH, Global Biostatistics & Data Sciences, Ingelheim, Germany -
P N Newsome Newsome
7 King’s College London & King’s College Hospital, Institute of Hepatology & Faculty of Life Sciences & Medicine, London, United Kingdom -
Q M Anstee
8 Newcastle University, Translational and Clinical Research Institute, Newcastle, United Kingdom -
G W Neff
9 Covenant Metabolic Specialists, Covenant Metabolic Specialists, Sarasota & Ft Myers, United States -
H O Coxson
10 Boehringer Ingelheim Pharma GmbH & Co. KG, TMTCP, Biberach, Germany -
E Lawitz
11 University of Texas Health San Antonio, Texas Liver Institute, San Antonio, United States -
V Ratziu
12 Sorbonne Universite, The Institute of Cardiometabolism and Nutrition, Paris, France -
A Nakajima
13 Yokohama City University Graduate School of Medicine, Department of Gastroenterology and Hepatology, Yokohama, Japan -
A Hosseini-Tabatabaei
14 Boehringer Ingelheim Pharmaceuticals Inc., CRM Medicine, Ridgefield, United States -
A J Sanyal
15 Virginia Commonwealth University, Division of Gastroenterology, Hepatology and Nutrition, Richmond, United States -
R Younes
16 Boehringer Ingelheim International GmbH, CRM Medicine, Ingelheim, Germany
